Fougera Pharmaceuticals Inc. (formerly Nycomed US Inc.)
United StatesEntry
2005
Hold
7yr
Exit
2012
Who owns Fougera Pharmaceuticals Inc. (formerly Nycomed US Inc.)?
Fougera Pharmaceuticals Inc. (formerly Nycomed US Inc.) is an American Pharma company, now owned by Sandoz, which acquired it in 2012 from Nordic Capital.
Hand-verified · updated 2026-08-18
Open JSON · CC-BY
Exit Type
Trade Sale
Buyer
Sandoz (Novartis)
Exit Year
2012
More from Nordic Capital (early funds)
Other portfolio companies in the same fund.
Bufab
Exited 2014
Industrials
Sweden· 2005
Sweden· 2005Cloetta
Exited 2013
ConsumerSweden· 2005
Sweden· 2005FinnvedenBulten
3.0xExited 2011
MobilitySweden· 2005
Sweden· 2005Kompan
Exited 2014
Consumer
Denmark· 2005
Denmark· 2005to Christian Dyvig, PFA pension fund and KOMPAN management
Luvata
Exited 2014
Industrials
Finland· 2005
Finland· 2005to Mitsubishi Materials
Plastal
Exited 2009
MobilitySweden· 2005
Sweden· 2005More PE-backed in Pharma
Comparable pharma deals from other GPs.
France
SpainQuestions
Who owns Fougera Pharmaceuticals Inc. (formerly Nycomed US Inc.)?
Fougera Pharmaceuticals Inc. (formerly Nycomed US Inc.) is now owned by Sandoz, which acquired it in 2012 from Nordic Capital.
When did Sandoz acquire Fougera Pharmaceuticals Inc. (formerly Nycomed US Inc.)?
Sandoz acquired Fougera Pharmaceuticals Inc. (formerly Nycomed US Inc.) in 2012, buying from Nordic Capital.
Who did Fougera Pharmaceuticals Inc. (formerly Nycomed US Inc.) sell to?
Nordic Capital sold Fougera Pharmaceuticals Inc. (formerly Nycomed US Inc.) to Sandoz in 2012 (Trade Sale).
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue